Archives
-
CDK1–APE1 Signaling in NSCLC: Repair and Immunity
2026-09-17
This study identifies CDK1-mediated phosphorylation of APE1 at Ser54 as a regulatory link between cell-cycle control, DNA repair, metastatic behavior, and immune signaling in NSCLC. Its findings support a therapeutic model in which WEE1 inhibition, APE1 targeting, and PD-L1 blockade are coordinated while also defining p53 status as an important determinant of metastatic response.
-
AG-221: A Causal Assay Framework for IDH2 AML
2026-09-17
AG-221 (Enasidenib) provides a precise way to interrogate mutant IDH2 biology in AML. This article develops a causal assay framework connecting 2-hydroxyglutarate reduction, CD44-dependent metabolic rewiring, and leukemia cell differentiation.
-
Lithium, Exosomal Wnt10a, and Bone Regeneration
2026-09-16
The reference study identifies a secretory mechanism through which lithium enhances BMSC osteogenesis: MARK2-dependent Rab11a/Rab11FIP1 trafficking increases exosomal Wnt10a delivery and activates β-catenin signaling. Its comparison of lithium-engineered exosomes and GelMA hydrogels provides a useful framework for developing cell-free, pathway-informed bone regeneration strategies.
-
Brefeldin A Workflows for ER Stress and Trafficking
2026-09-16
Brefeldin A connects ER-to-Golgi trafficking disruption with ER stress, cytoskeletal remodeling, and apoptosis in cell-based assays. This practical guide shows how to build dose–time workflows, distinguish trafficking phenotypes from nonspecific toxicity, and apply BFA to cancer and protein quality-control studies.
-
Brefeldin A: From Trafficking Stress to Translation
2026-09-15
Brefeldin A (BFA) is more than a conventional secretion inhibitor: it is a mechanistic perturbation tool that links ER-to-Golgi trafficking, ER stress, cytoskeletal organization, and cancer-cell fate. This article outlines how translational researchers can use BFA to build stronger disease models while distinguishing established evidence from testable hypotheses in endothelial injury and sepsis.
-
N6-Methyl-dATP for Reliable Fidelity Studies
2026-09-15
Learn how N6-Methyl-dATP (SKU B8093) can help biomedical researchers distinguish nucleotide-recognition effects from true changes in cell proliferation or viability. This scenario-driven guide covers experimental controls, storage, interpretation, and practical vendor-selection criteria for DNA replication fidelity and methylation modification research.
-
N6-Methyl-dATP: From Chemistry to Assay Design
2026-09-14
N6-Methyl-dATP is more than a methylated nucleotide analog: it is a controlled perturbation for polymerase and nucleic-acid interaction studies. This article connects its chemistry with assay decisions inspired by the LMO2/LDB1 AML study while defining practical limits for epigenetic and translational research.
-
Amyloid Beta-peptide (25-35): Practical AD Workflows
2026-09-14
Build reproducible neuronal and microglial injury assays with Aβ25-35, from controlled reconstitution through mitochondrial, ROS, viability, and inflammatory readouts. The workflow also connects fragment-induced stress phenotypes with the FLOT1–FOSL2–EphA2 pathway described in a recent Alzheimer’s disease study.
-
Ionomycin Free Acid for Calcium–FAK Workflows
2026-09-13
Use Ionomycin free acid as an acute calcium ion transport tool to test whether calcium-dependent proteolysis intersects with FAISL–FAK signaling in triple-negative breast cancer. The same reagent also supports distinct oocyte activation studies, but each application requires separate controls, dose finding, and endpoint validation.
-
Recombinant Human IL-15 Assay Workflows
2026-09-12
Build reproducible T-cell and NK-cell assays with a tag-free, low-endotoxin cytokine input. This guide translates product specifications into practical reconstitution, titration, assay, and troubleshooting workflows while placing emerging neuroimmune questions in the correct evidentiary context.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-09-11
Build sensitive translation, gene regulation, and delivery assays with a Cap1-structured firefly luciferase transcript. This practical guide connects RNase-aware handling and transfection design with lipid nanoparticle size selection for more reproducible in vitro and in vivo readouts.
-
Ceftolozane/Tazobactam: Evidence and Research Design
2026-09-10
Cho, Fiorenza, and Estrada review ceftolozane/tazobactam as an antipseudomonal cephalosporin–beta-lactamase inhibitor combination designed to address resistant gram-negative pathogens. The paper’s main contribution is its integrated analysis of PBP activity, resistance coverage, pharmacokinetics, pharmacodynamics, clinical indications, and safety, providing a framework for interpreting translational antibacterial evidence.
-
EZ Cap™ Cy5 EGFP mRNA: Dual-Readout Assay Guide
2026-09-10
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is a Cy5-labeled mRNA reporter that separates cellular delivery from EGFP protein expression. Its Cap1 structure, 5-moUTP modification, and dual fluorescence support an mRNA delivery and translation efficiency assay, but fluorescent uptake alone does not prove productive cytosolic translation.
-
HCAR3 Structures Reveal Agonist Selectivity
2026-09-09
The 2025 PLOS Biology study defines how selective agonists recognize HCAR3/GPR109B and how subtle pocket differences distinguish HCAR3 from HCAR2/GPR109A. By combining cryo-EM structures with cAMP assays, the work provides a structural framework for lipid signaling pathway modulation and the design of HCAR3-directed research tools.
-
Salinomycin in Hepatocellular Carcinoma Research
2026-09-09
Salinomycin is a polyether ionophore antibiotic investigated as a multi-pathway research tool in hepatocellular carcinoma models. Product-described activity includes ABC transporter interference, Wnt/β-catenin signaling pathway inhibition, calcium elevation, growth suppression, and apoptosis-associated changes, but these findings do not establish clinical efficacy.